51
Participants
Start Date
June 30, 2022
Primary Completion Date
May 21, 2024
Study Completion Date
May 21, 2024
V117957
V117957 1 mg - 1 tablet taken orally at bedtime.
Placebo
Placebo to match V117957 tablets - 1 tablet taken orally at bedtime.
AccuMed Research Associates, Garden City
The Clinical Trial Center, LLC, Jenkintown
Unified Women's Clinical Research-Lyndhurst, Winston-Salem
Providea Health Partners, LLC, Evergreen Park
DelRicht Research, New Orleans
Ochsner LSU Health Shreveport - Regional Urology, Shreveport
Arizona Urology Specialists, PLLC, Tucson
Urology Group of Southern California, Los Angeles
ARK Clinical Research, Long Beach
Hope Clinical Research, LLC, Canoga Park
Boston Clinical Trials, Boston
Bay State Clinical Trials, Inc., Watertown
Lead Sponsor
Purdue Pharma LP
INDUSTRY
Imbrium Therapeutics
INDUSTRY